Bevacizumab Related Hypertension and Reversible Posterior Leukoencephalopathy Syndrome in Gynecologic Malignancies: A case Control Study

Journals Menu

Follow SCIRP

ISSN Print: 2151-1934
ISSN Online: 2151-1942
www.scirp.org/journal/jct
E-mail: jct@scirp.org

Citations h5-index & Ranking

"Bevacizumab Related Hypertension and Reversible Posterior Leukoencephalopathy Syndrome in Gynecologic Malignancies: A case Control Study"
written by Sarah N. Cross, Elena S. Ratner, Dan A. Silasi, Alessandro D. Santin, Masoud Azodi, Thomas J. Rutherford, Peter E. Schwartz,
published by Journal of Cancer Therapy, Vol.2 No.2, 2011

has been cited by the following article(s):

[1]	Bevacizumab-mediated interference with VEGF signaling is sufficient to induce a preeclampsia-like syndrome in nonpregnant women
	Reviews in obstetrics …, 2012

[2]	Clinical Benefit and Toxicity of Continuing Bevacizumab Containing Chemotherapies in Patients with Recurrent Ovarian Cancer
	Cancer …, 2012

[3]	Clinical Benefit and Toxicity of Continuing Bevacizumab Containing Chemotherapies in Patients with Recurrent Ovarian Cancer.
	Cancer Therapy, 2011

Follow SCIRP